- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04372745
Home Pregnancy Test Evaluation, Lay User Study
Evaluation of Home Pregnancy Test by Lay Users Study
This study is a performance evaluation study to assess the performance of a home pregnancy test (HPT) in the hands of lay users by comparing their results, when used according to the Instructions for Use (IFU), to (a) the lay user confirmed pregnancy status, as determined by a CE marked product, and (b) to trained technicians testing the same urine samples.
The study will also assess the lay user's ability to correctly read results from randomised standards, in addition to leaflet comprehension and product ease of use.
Study Overview
Status
Conditions
Detailed Description
This is an observational study, designed to assess the performance of a home pregnancy test.
The study aims to recruit at total 120 volunteers, being approximately equal numbers of 'pregnant' and not-pregnant' women. Volunteers will be recruited either via direct invitation or advertisement and will attend the study site for one visit lasting 30-40 minutes
Written informed consent will be obtained from all volunteers prior to starting the study.
All volunteers will be issues a unique study number on admission to the study. All data and samples collected will be anonymised throughout the study.
Volunteers will be provided with one investigational home pregnancy test and instructions for use. They will be asked to conduct the test, following the product instructions to obtain a test result which will be recorded on the result sheet. Volunteers will be instructed the product is investigational and the results should not be relied upon to determine their pregnancy status.
Study volunteers will then be interviewed by the study technician, with regards to their understanding of the product instructions and complete an ease of use questionnaire. The comprehension interview may be recorded.
The study technician will then perform 2 further investigational home pregnancy tests on randomised urine standards and the volunteer will read the results.
Finally, the study technician will test the volunteer's urine sample with a marketed pregnancy test and record these results on the results sheet. The results of this test will be used to provide the volunteer with her pregnancy status at the end of the study.
Urine samples provided by the volunteers will be tested with the investigational HPT by an independent technician and also measured for hCG by quantitative immunoassay. Samples may also be measured for other hormones related to pregnancy and fertility.
With participant permission, the samples may be retained frozen within the SPD BioBank and used for future product evaluation or research purposes.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Bedfordshire
-
Bedford, Bedfordshire, United Kingdom, MK44 3UP
- SPD Development Company Ltd
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Willing to give informed consent
- Willing to conduct a personal home pregnancy test and reveal their pregnancy status
- Seeking to conceive, wishing to conduct a pregnancy test or having recently found out they are pregnant
Exclusion Criteria:
- Currently or previously employed by SPD, Abbott, Alere, Unipath, P&G or affiliates
- Has an immediate relative currently or previously (within last 5 years) employed by SPD, Abbott, Alere, Unipath or P&G, or affiliates
- Healthcare professionals (HCP's) with professional experience either using lateral flow-based devices or conducting near patient testing
- If pregnant, known to be beyond the first trimester (defined as last menstrual period, LMP +13 weeks)
- aken a hormonal preparation containing hCG in the last month, e.g. Pregnyl ®
- Has previously taken part in this study
- Seen the product within the past 6 months
Immediate relatives are defined as parents, children, siblings or partner/spouse
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Agreement with pregnancy status
Time Frame: 3 months
|
The accuracy of the investigational HPT will be calculated against the confirmed pregnancy status of the sample.
The corresponding 95% confidence interval will also be calculated for the measure.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Agreement with technician results
Time Frame: 3 months
|
The agreement between the lay-user and technician results when both testing the same sample with the investigational HPT as per the IFU.
The corresponding 95% confidence interval will also be calculated for the measure.
|
3 months
|
Comprehension of instructions for use
Time Frame: 3 months
|
The percentage number of correct answers in the IFU comprehension exercise
|
3 months
|
Ease of product use
Time Frame: 3 months
|
The cumulative Likert scores for ease of use questions on the device usability questionnaire will be calculated, using a 7 point likert scale, where 1 is equivalent to very easy and 7 is equivalent to very difficult.
|
3 months
|
Ability to read result
Time Frame: 3 months
|
The agreement between the lay-user read of a investigational HPT tested with a spiked standard against the expected result of the spiked standard.
The corresponding 95% confidence interval will also be calculated.
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sarah Johnson, SPD Development Company Ltd
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PROTOCOL-1146
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy Related
-
Helen Keller InternationalEleanor Crook FoundationNot yet recruitingPregnancy Related | Supplementation | Postnatal Related
-
4YouandMeCambridge Cognition Ltd; Sema4; Evidation Health; Vector Institute of Artificial... and other collaboratorsCompletedPregnancy Related | Wearables | Pregnancy EarlyUnited States
-
The University of Texas Health Science Center,...CompletedPregnancy Related | Pregnancy, High RiskUnited States
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Shaare Zedek Medical CenterUnknownPregnancy Related | Pregnancy, High Risk | Anesthesia
-
Atatürk UniversityNot yet recruiting
-
Medical College of WisconsinNot yet recruiting
-
University of PennsylvaniaNot yet recruiting
-
Centre for Infectious Disease Research in ZambiaWellcome Trust; Neopenda, PBCRecruiting
-
Emory UniversityNational Institute of Nursing Research (NINR)Recruiting